Concepedia

Boxian Pang

BP

Statistics

Publications

2

Citations

148

H-Index

2

Active since

2025

Affiliations

Shuguang Hospital(Current)

Chinese Academy of Medical Sciences & Peking Union Medical College

Shanghai University of Traditional Chinese Medicine

National Center for Nanoscience and Technology

Guang’anmen Hospital

Boxian Pang is an author at Shuguang Hospital specializing in anthracycline-induced cardiotoxicity, chemotherapy, and molecular pharmacology.

ORCID

Publications per year

2025–2025

2

Publications

2

Ligustrazine nano-drug delivery system ameliorates doxorubicin-mediated myocardial injury via piezo-type mechanosensitive ion channel component 1-prohibitin 2-mediated mitochondrial quality surveillance

Junyan Wang, Haowen Zhuang, Chun Li et al. · Journal of Nanobiotechnology · 2025 · 101 citations · Full text

, , +16

A novel ligustrazine-based nanodelivery system protects against doxorubicin-induced cardiotoxicity by targeting the SIRT5–DUSP1 axis for mitochondrial repair

Hongshuo Shi, Boxian Pang, Fenglei Zhang et al. · Journal of Nanobiotechnology · 2025 · 47 citations · Full text

, , +17

1–2 of 2